FDA’s Real World Study On Adoption Of PD-1 Dosing Change Aims To Inform Reviewers – In Vivo



FDA’s Real World Study On Adoption Of PD-1 Dosing Change Aims To Inform Reviewers  In Vivo

Study using US FDA’s Information Exchange and Data Transformation (INFORMED) program will focus on shift from weight-based to flat dosing for Opdivo and …



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *